332MO Comparison of NEPA-based versus olanzapine/aprepitant-based antiemetic regimen for Chinese breast cancer patients undergoing highly emetogenic chemotherapy

Autor:	Elizabeth Pang, Carol Kwok, Winnie Yeo, Kwai Tung Lai, V.T. Chan, Thomas K.H. Lau, Christopher C. H. Yip, Maggie Cheung, Frankie Kf Mo, V.W.Y. Chan, Leung Li
Rok vydání:	2020
Předmět:	Oncology Olanzapine medicine.medical_specialty business.industry Hematology medicine.disease Breast cancer Antiemetic regimen Internal medicine medicine business Highly emetogenic chemotherapy Aprepitant medicine.drug
Zdroj:	Annals of Oncology. 31:S1371
ISSN:	0923-7534
DOI:	10.1016/j.annonc.2020.10.326
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::a87efe60f55dcf7b5c253004ebf44d7d https://doi.org/10.1016/j.annonc.2020.10.326 Zobrazit plný text záznamu